CDC2 in G2 Arrest and Cell Death by Antitumor Agents - Richard Lock

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 5R29CA053184-05
Application #: 2095235
Study Section: Experimental Therapeutics Subcommittee 1 (ET)

Project Start: 1991-02-01
Project End: 1997-01-31
Budget Start: 1995-02-01
Budget End: 1997-01-31
Support Year: 5
Fiscal Year: 1995
Total Cost
Indirect Cost

Institution

Name: University of Louisville
Department: Internal Medicine/Medicine
Type: Schools of Medicine
DUNS #

City: Louisville
State: KY
Country: United States
Zip Code: 40292

Related projects


NIH 1995 R29 CA	CDC2 in G2 Arrest and Cell Death by Antitumor Agents Lock, Richard B. / University of Louisville
NIH 1994 R29 CA	CDC2 in G2 Arrest and Cell Death by Antitumor Agents Lock, Richard B. / University of Louisville
NIH 1993 R29 CA	CDC2 in G2 Arrest and Cell Death by Antitumor Agents Lock, Richard B. / University of Louisville
NIH 1992 R29 CA	CDC2 in G2 Arrest and Cell Death by Antitumor Agents Lock, Richard B. / University of Louisville
NIH 1991 R29 CA	CDC2 in G2 Arrest and Cell Death by Antitumor Agents Lock, Richard B. / University of Louisville

Comments

Be the first to comment on Richard Lock's grant